Company Overview of MPM Capital
MPM Capital is a private equity and venture capital firm specializing in seed, startup, early ventures, emerging growth, middle market, mature, mid venture, late venture, buyout, recapitalization, PIPES, and growth equity investments. The firm makes its venture investments through its MPM BioVentures fund and invests in the public markets through MPM BioEquities hedge fund. It invests in growth stage in in the biotechnology, healthcare, and life sciences sector. It invests in the seed stage through early clinical development stage of a company and invests in late stage in biopharmaceutical and diagnostics companies with clinical proof-of-concept data. It prefers to invest in medical technolo...
450 Kendall Street
Cambridge, MA 02142
Founded in 1996
Key Executives for MPM Capital
Co-Founder, Managing Director and Managing Partner
Chief Operating Officer and General Counsel
Compensation as of Fiscal Year 2015.
MPM Capital Key Developments
MPM Capital Appoints Briggs W. Morrison, M.D. as Managing Director
Jun 22 15
MPM Capital announced the appointment of Briggs W. Morrison, M.D., to the position of Managing Director. Dr. Morrison was recently appointed Chief Executive Officer of Syndax Pharmaceuticals Inc., after serving as Chief Medical Officer and Executive Vice President for R&D at AstraZeneca.
MPM Capital Appoints Pablo J. Cagnoni, M.D. as Managing Director
May 20 15
MPM Capital announced the appointment of former President of Onyx Pharmaceuticals Pablo J. Cagnoni, M.D. as Managing Director (MD). In addition to serving as an MPM MD, Dr. Cagnoni is a co-founder of Vesuvius, an MPM-founded cancer immunotherapy company, and has taken on the role of President and Chief Executive Officer. Over of the course of his career as an oncologist and pharmaceutical executive, Dr. Cagnoni has been committed to advancing the development of breakthrough treatments for patients with cancer and other debilitating diseases. He has played a key role in the development, approval and/or commercialization of several life-changing medicines, including Afinitor®, Blinctyo®, Exjade®, Folotyn®, Glivec®, Jakavi®, Kyprolis®, Signifor®, Tarceva® and Tasigna®, among them.
MPM Capital Presents at Boston CEO Conference, May-27-2015 10:50 AM
Apr 16 15
MPM Capital Presents at Boston CEO Conference, May-27-2015 10:50 AM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Ansbert K. Gadicke, Co-Founder, Managing Director, and General Partner.
Similar Private Companies By Industry
Recent Private Companies Transactions